Alpine Global Management’s Astera Labs ALAB Stock Holding History

Alpine Global Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,668	Closed	-$272K	–	533
2024 Q1	$272K	Buy	+3,668	New	+$272K	0.05%	148

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

Alpine Global Management's ALAB Position: Q2 2024 in Review

Alpine Global Management sold out of Astera Labs (ALAB) in Q2 2024, closing a stake of 3,668 shares — an estimated $272K sold.

Alpine Global Management first reported a position in ALAB in Q1 2024 and held it in 1 quarter. The position peaked at $272K in Q1 2024. 146 funds tracked by Wall St. Rank hold ALAB as of Q2 2024.

Alpine Global Management reported no remaining Astera Labs position as of Q2 2024 after selling out during the quarter.
Alpine Global Management sold 3,668 Astera Labs shares in Q2 2024, an estimated $272K.
Alpine Global Management first reported a position in Astera Labs in Q1 2024 and held it in 1 quarter.
Alpine Global Management's Astera Labs position peaked at $272K in Q1 2024.
146 funds tracked by Wall St. Rank held Astera Labs as of Q2 2024.

Based on Alpine Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.